Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stuart Poulton currently holds 67,392 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Poulton has been a net seller of KPTI stock. They have purchased $0 and sold $64.3K worth of shares.
Stuart Poulton's most recent insider trade was on Oct 15, 2025, when they sold 39,682 shares at $0.00 per share.
Stuart Poulton serves as Executive at Karyopharm Therapeutics Inc. (KPTI). They have executed 16 insider transactions totaling $64.3K over their tenure at the company.
Stuart Poulton holds the position of Executive at Karyopharm Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Stuart Poulton has shown a selling trading pattern, with $0 in total purchases and $64.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stuart Poulton was on Feb 29, 2024, when they sold $19.1K worth of KPTI shares. This transaction involved 16,311 shares at $1.17 per share.
Stuart Poulton currently owns 67,392 shares of Karyopharm Therapeutics Inc. (KPTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stuart Poulton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stuart Poulton has 16 Form 4 filings on record as an insider at Karyopharm Therapeutics Inc..
Set alerts for Stuart Poulton and 40,000+ other insiders.